Sep 7, 2016
UPMC-backed Cernostics precision medicine technology gets $5 million boost
Healthcare IT News- Oncology diagnostics company Cernostics has pulled in a $5 million round of funding led by UPMC Enterprises, the commercial arm of UPMC.
The funding will go toward growing and accelerating a new diagnostic test for people with Barrett’s Esophagus, a condition that can lead to cancer.
UPMC Enterprises is also partnering with Cernostics to do the work.
